Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chlorpromazine added to atazanavir/ritonavir for hospitalized adults with COVID-19
IRCT20200913048708N1Phase 2Completed
- Sponsor
- Mazandaran University of Medical Sciences
- Start
- Oct 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of Aminazin in coronavirus disease 2019 (COVID-19) (2 arms), sponsored by Mazandaran University of Medical Sciences. Primary endpoint: Daily oxygen saturation. Started Oct 2020; status: completed.
02
Drugs
Aminazin
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on IRCT20200913048708N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200913048708N1.